Dermatofibroma physical examination: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
WikiBot (talk | contribs)
Bots, Bureaucrats, bureaucrats, interwiki, nocaptcha, Administrators
57,550 edits
m Bot: Removing from Primary care
 
(12 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Dermatofibroma}}
{{Dermatofibroma}}
Line 5: Line 4:


==Overview==
==Overview==
 
[[Physical examination]] of [[patients]] with dermatofibroma is usually shows a non-tender, [[Pigment|hyperpigmented]] [[Nodule (medicine)|nodule]] with 0.3 to 1 [[Centimetre|cm]] in [[diameter]] which dimple sign may be positive. It can seen in any part of the [[body]] but [[extremities]], especially [[legs]] are most common sites.
Dermatofibromas can be found anywhere on the body, but most often they are found on the legs and arms.
 
==Physical Examination==
 
Dermatofibromas can be found anywhere on the body, but most often they are found on the legs and arms. A dermatofibroma is associated with the dimple sign; by applying lateral pressure, there is a central depression of the dermatofibroma.
===Skin===
 
===Extremities===
* Hard [[papule]]s (rounded bumps) that may appear in a variety of colors, usually brownish to tan.
** Especially found on the legs.
 
==Overview==
Patients with [disease name] usually appear [general appearance]. Physical examination of patients with [disease name] is usually remarkable for [finding 1], [finding 2], and [finding 3].
 
OR
 
Common physical examination findings of [disease name] include [finding 1], [finding 2], and [finding 3].
 
OR
 
The presence of [finding(s)] on physical examination is diagnostic of [disease name].
 
OR
 
The presence of [finding(s)] on physical examination is highly suggestive of [disease name].
 
<br />


==Physical Examination==
==Physical Examination==
Physical examination of patients with [disease name] is usually normal.
[[Physical examination]] of [[patients]] with dermatofibroma is usually shows a non-tender, [[Pigment|hyperpigmented]] [[Nodule (medicine)|nodule]] with 0.3 to 1 [[Centimetre|cm]] in [[diameter]] which dimple sign may be positive. It can seen in any part of the [[body]] but [[extremities]], especially [[legs]] are most common sites.
 
OR
 
Physical examination of patients with [disease name] is usually remarkable for [finding 1], [finding 2], and [finding 3].
 
OR
 
The presence of [finding(s)] on physical examination is diagnostic of [disease name].
 
OR
 
The presence of [finding(s)] on physical examination is highly suggestive of [disease name].


===Skin===
===Skin===
* Skin examination of patients with dermatofibroma may shows:
*[[Skin]] [[examination]] of [[patients]] with dermatofibroma may show:<ref name="LeeLee2015">{{cite journal|last1=Lee|first1=MiWoo|last2=Lee|first2=WooJin|last3=Jung|first3=JoonMin|last4=Won|first4=ChongHyun|last5=Chang|first5=SungEun|last6=Choi|first6=JeeHo|last7=Moon|first7=KeeChan|title=Clinical and histological patterns of dermatofibroma without gross skin surface change: A comparative study with conventional dermatofibroma|journal=Indian Journal of Dermatology, Venereology, and Leprology|volume=81|issue=3|year=2015|pages=263|issn=0378-6323|doi=10.4103/0378-6323.154795}}</ref><ref name="MentzelWiesner2012">{{cite journal|last1=Mentzel|first1=Thomas|last2=Wiesner|first2=Thomas|last3=Cerroni|first3=Lorenzo|last4=Hantschke|first4=Markus|last5=Kutzner|first5=Heinz|last6=Rütten|first6=Arno|last7=Häberle|first7=Michael|last8=Bisceglia|first8=Michele|last9=Chibon|first9=Frederic|last10=Coindre|first10=Jean-Michel|title=Malignant dermatofibroma: clinicopathological, immunohistochemical, and molecular analysis of seven cases|journal=Modern Pathology|volume=26|issue=2|year=2012|pages=256–267|issn=0893-3952|doi=10.1038/modpathol.2012.157}}</ref><ref name="FitzpatrickGilchrest1977">{{cite journal|last1=Fitzpatrick|first1=Thomas B.|last2=Gilchrest|first2=Barbara A.|title=Dimple Sign to Differentiate Benign from Malignant Pigmented Cutaneous Lesions|journal=New England Journal of Medicine|volume=296|issue=26|year=1977|pages=1518–1518|issn=0028-4793|doi=10.1056/NEJM197706302962610}}</ref><ref>{{Cite journal
*Nodule with 0.3 to 1 cm in diameter
| author = [[Marc Pusztaszeri]], [[Pierre-Yves Jaquet]] & [[Carole Williamson]]
 
| title = Giant hemosiderotic dermatofibroma: a case report and review of the literature
*Hyperpigmented
| journal = [[Case reports in dermatology]]
*Dimple sign ( lateral compression on the skin makes a depression)
| volume = 3
*Puritic ( may happen by manipulation)
| issue = 1
*
| pages = 32–36
 
| year = 2011
*Typically, the clinical appearance of dermatofibroma is a solitary, 0.5- to 1-cm nodule. A sizable minority of patients may have several lesions, but rarely (< 1% of cases) are more than 15 lesions present. (See History) The overlying skin can range from flesh to gray, yellow, orange, pink, red, purple, blue, brown, or black, or a combination of hues (see the image below). On palpation, the hard nodule may feel like a small pebble fixed to the skin surface and is freely movable over the subcutis. Tenderness may be elicited with manipulation of the lesion. The characteristic tethering of the overlying epidermis to the underlying lesion with lateral compression (pinching), called the dimple sign, may be a useful clinical sign for diagnosis. <sup>[49]</sup> However, presence of the dimple sign does not always assure the lesion is dermatofibroma, <sup>[50]</sup> and dermatoscopy may be useful in supporting the clinical impression. <sup>[51]</sup>  The extremities are the most common sites of involvement, particularly the legs.<sup>[19, 20]</sup> Although any cutaneous site can be seen, palm, sole, digital, oral, and genital involvement is relatively rare. Giant (>5 cm in diameter), <sup>[52]</sup> atrophic, <sup>[53]</sup>polypoid, <sup>[54]</sup> and dermatofibroma with spreading satellitosis <sup>[55]</sup> variants have been reported. The largest reported tumor was 17 x 9 x 4 cm. <sup>[56]</sup>  Multiple clustered dermatofibromas <sup>[48]</sup> are rare and can mimic dermatofibrosarcoma protuberans. This phenomenon has been reported in a segmental distribution. <sup>[57]</sup>  A halo of dermatitis (Meyerson phenomenon) surrounding a dermatofibroma occurred in one patient.
| month =
 
| doi = 10.1159/000324721
Dermatofibromas typically present as firm, often hyperpigmented, nodules 0.3 to 1 cm in diameter (picture 4A-B), but giant lesions larger than 3 cm in diameter have been described [11,12]. They occur most often in adults and are most commonly located on the lower extremities. Lesions are usually asymptomatic, but may be pruritic. On palpations, dermatofibromas are fixed to the subcutaneous tissues and characteristically dimple when pinched
| pmid = 21487458
|url=|first=|date=|via=}}</ref><ref>{{Cite journal
| author = [[L. Requena]], [[M. C. Farina]], [[C. Fuente]], [[E. Pique]], [[M. Olivares]], [[L. Martin]] & [[E. Sanchez Yus]]
| title = Giant dermatofibroma. A little-known clinical variant of dermatofibroma
| journal = [[Journal of the American Academy of Dermatology]]
| volume = 30
| issue = 5 Pt 1
| pages = 714–718
| year = 1994
| month =
| pmid = 8176009
|url=|first=|date=|via=}}</ref>
**[[Nodule (medicine)|Nodule]] with 0.3 to 1 [[Centimetre|cm]] in [[diameter]]
***'''Note''' : Giant (> 5 [[Centimetre|cm]]) are also reported.
** Non-tender [[nodule]]
***'''Note''': Manipulation can cause [[tenderness]].
**[[Hyperpigmentation]]
**[[Dimple]] [[Medical sign|sign]] ([[lateral]] compression on the [[skin]] makes a depression)
***'''Note''': [[Dimple]] [[Medical sign|sign]] can also seen in other [[skin changes]].
** Puritic [[Nodule (medicine)|nodule]] (may happen by [[superinfection]])
[[File:Dimple sign.jpg|350px|thumb|https://www.dermnetnz.org/topics/dermatofibroma-images/|center]]
[[File:Hyperpigmentation in dermatofibroma.jpg|350px|thumb|https://www.dermnetnz.org/topics/dermatofibroma-images/|center]]


===Extremities===
===Extremities===
* Extremities examination of patients with [disease name] is usually normal.
*[[Extremities]] are the most common site of dermatofibromas, especially [[Leg|legs]].<ref name="ŞenelYuyucu Karabulut2015">{{cite journal|last1=Şenel|first1=E.|last2=Yuyucu Karabulut|first2=Y.|last3=Doğruer Şenel|first3=S.|title=Clinical, histopathological, dermatoscopic and digital microscopic features of dermatofibroma: a retrospective analysis of 200 lesions|journal=Journal of the European Academy of Dermatology and Venereology|volume=29|issue=10|year=2015|pages=1958–1966|issn=09269959|doi=10.1111/jdv.13092}}</ref><ref name="HanChang2011">{{cite journal|last1=Han|first1=Tae Young|last2=Chang|first2=Hee Sun|last3=Lee|first3=June Hyun Kyung|last4=Lee|first4=Won-Mi|last5=Son|first5=Sook-Ja|title=A Clinical and Histopathological Study of 122 Cases of Dermatofibroma (Benign Fibrous Histiocytoma)|journal=Annals of Dermatology|volume=23|issue=2|year=2011|pages=185|issn=1013-9087|doi=10.5021/ad.2011.23.2.185}}</ref>
OR
*[[Clubbing]]  
*[[Cyanosis]]  
*Pitting/non-pitting [[edema]] of the upper/lower extremities
*Muscle atrophy
*Fasciculations in the upper/lower extremity
 


==References==
==References==
{{reflist|2}}
{{reflist|2}}


[[Category:Medicine]]
[[Category:Medicine]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date]]
[[Category:Primary care]]
[[Category:Dermatology]]
[[Category:Dermatology]]

Latest revision as of 21:18, 29 July 2020

Dermatofibroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dermatofibroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dermatofibroma physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dermatofibroma physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dermatofibroma physical examination

CDC on Dermatofibroma physical examination

Dermatofibroma physical examination in the news

Blogs on Dermatofibroma physical examination

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Dermatofibroma physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Kiran Singh, M.D. [3]

Overview

Physical examination of patients with dermatofibroma is usually shows a non-tender, hyperpigmented nodule with 0.3 to 1 cm in diameter which dimple sign may be positive. It can seen in any part of the body but extremities, especially legs are most common sites.

Physical Examination

Physical examination of patients with dermatofibroma is usually shows a non-tender, hyperpigmented nodule with 0.3 to 1 cm in diameter which dimple sign may be positive. It can seen in any part of the body but extremities, especially legs are most common sites.

Skin

https://www.dermnetnz.org/topics/dermatofibroma-images/
https://www.dermnetnz.org/topics/dermatofibroma-images/

Extremities

References

  1. ↑ Lee, MiWoo; Lee, WooJin; Jung, JoonMin; Won, ChongHyun; Chang, SungEun; Choi, JeeHo; Moon, KeeChan (2015). "Clinical and histological patterns of dermatofibroma without gross skin surface change: A comparative study with conventional dermatofibroma". Indian Journal of Dermatology, Venereology, and Leprology. 81 (3): 263. doi:10.4103/0378-6323.154795. ISSN 0378-6323.
  2. ↑ Mentzel, Thomas; Wiesner, Thomas; Cerroni, Lorenzo; Hantschke, Markus; Kutzner, Heinz; Rütten, Arno; Häberle, Michael; Bisceglia, Michele; Chibon, Frederic; Coindre, Jean-Michel (2012). "Malignant dermatofibroma: clinicopathological, immunohistochemical, and molecular analysis of seven cases". Modern Pathology. 26 (2): 256–267. doi:10.1038/modpathol.2012.157. ISSN 0893-3952.
  3. ↑ Fitzpatrick, Thomas B.; Gilchrest, Barbara A. (1977). "Dimple Sign to Differentiate Benign from Malignant Pigmented Cutaneous Lesions". New England Journal of Medicine. 296 (26): 1518–1518. doi:10.1056/NEJM197706302962610. ISSN 0028-4793.
  4. ↑ Marc Pusztaszeri, Pierre-Yves Jaquet & Carole Williamson (2011). "Giant hemosiderotic dermatofibroma: a case report and review of the literature". Case reports in dermatology. 3 (1): 32–36. doi:10.1159/000324721. PMID 21487458.
  5. ↑ L. Requena, M. C. Farina, C. Fuente, E. Pique, M. Olivares, L. Martin & E. Sanchez Yus (1994). "Giant dermatofibroma. A little-known clinical variant of dermatofibroma". Journal of the American Academy of Dermatology. 30 (5 Pt 1): 714–718. PMID 8176009.
  6. ↑ Şenel, E.; Yuyucu Karabulut, Y.; Doğruer Şenel, S. (2015). "Clinical, histopathological, dermatoscopic and digital microscopic features of dermatofibroma: a retrospective analysis of 200 lesions". Journal of the European Academy of Dermatology and Venereology. 29 (10): 1958–1966. doi:10.1111/jdv.13092. ISSN 0926-9959.
  7. ↑ Han, Tae Young; Chang, Hee Sun; Lee, June Hyun Kyung; Lee, Won-Mi; Son, Sook-Ja (2011). "A Clinical and Histopathological Study of 122 Cases of Dermatofibroma (Benign Fibrous Histiocytoma)". Annals of Dermatology. 23 (2): 185. doi:10.5021/ad.2011.23.2.185. ISSN 1013-9087.
Retrieved from "https://www.wikidoc.org/index.php?title=Dermatofibroma_physical_examination&oldid=1636997"